Investigational Site Number : 4100002

Suwon, Gyeonggi-do 16499

1 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Immunoglobulin G4 Related Disease

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling